SCHEMBL4906496

SCHEMBL4906496

CCN(c1ccc(OCc2ccc(F)c(F)c2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
MAOA P21397 2/20 0.45
MAOB P27338 2/20 0.45
KMT2A Q03164 1/20 0.41
PPARA Q07869 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ESR1 P03372 1/20 0.39
KEAP1 Q14145 3/20 0.39
NFE2L2 Q16236 3/20 0.39
TSHR P16473 1/20 0.39
MME P08473 1/20 0.39
ACE P12821 1/20 0.39
CPA1 P15085 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
ANO1 Q5XXA6 1/20 0.39
ACHE P22303 1/20 0.38
MMP9 P14780 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911874 0.91 MAOA (0.43) LMNAMAOAMAOBKMT2APPARA
SCHEMBL4897627 0.91 KEAP1 (0.48) LMNAMAOAMAOBKMT2APPARA
SCHEMBL4903420 0.90 LMNA (0.57) LMNAMAOAMAOBKMT2APPARA
SCHEMBL4906732 0.89 LMNA (0.47) LMNAMAOBKMT2AALDH1A1HPGD
SCHEMBL4897727 0.86 MMP2 (0.48) LMNAMAOBPPARAKEAP1NFE2L2
SCHEMBL4906250 0.86 LMNA (0.57) LMNAMAOAMAOBKMT2APPARA
SCHEMBL4907012 0.84 LMNA (0.49) LMNAKMT2AALDH1A1HPGDALOX15
SCHEMBL4897505 0.83 LMNA (0.54) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906453 0.83 LMNA (0.48) LMNAMAOAMAOBALDH1A1ESR1
SCHEMBL4907053 0.82 LMNA (0.48) LMNAKMT2AALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885MAOA 4248/4885MAOB 4263/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885MAOA 4248/4885MAOB 4263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.